Influence of Lifestyle Modification in Renal Transplant Recipients With Postprandial Hyperglycemia
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Lifestyle modification is recommended as first-line therapy to manage new-onset diabetes after transplantation (NODAT) and impaired glucose tolerance (IGT). No data currently demonstrate the efficacy of this approach specifically for transplant recipients. This study aimed to assess the benefit of intensive lifestyle modification in this high-risk group and to contrast this with the natural evolution of glucose metabolism after transplantation. METHODS: Baseline oral glucose tolerance test (OGTT) stratified 115 patients into two groups. Group 1 had glucose intolerance, IGT (n=28) and NODAT (n=8), and received intensive lifestyle modification (dietician referral, exercise program, weight loss advice). Group 2 had normal glucose tolerance (n=79) and received lifestyle modification leaflets. Both groups had follow-up OGTT after 6 months to assess change in glycemic status. RESULTS: Excluding all patients who received steroid weaning or withdrawal as part of their management, 111 patients were included in the analysis. Lifestyle modification in group 1 resulted in 15% improvement in 2-hr postprandial glucose versus 12% deterioration in group 2. In group 1, 44% (n=11) of IGT patients developed normal glucose tolerance, whereas only 4% (n=1) developed NODAT. Fifty-eight percent (n=4) of NODAT patients showed improvement (29% to IGT and 29% to normal). Glucose metabolism deteriorated in group 2 with 14% (n=10) developing IGT and 3% (n=2) developing NODAT. CONCLUSIONS: Glucose metabolism can deteriorate in transplant recipients despite passive lifestyle modification advice. This study shows active lifestyle modification benefits high-risk transplant recipients with glucose intolerance and should be aggressively pursued.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Presentation may range from mild hyperglycemia to frank DM, ranging from 1% to 6%.1606,1607”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1606]
Citations
Cites
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“(20) showed how the cumulative incidence of diabetes in a lifestyle intervention group was 11% compared with 23% in a TABLE 3.”
ResultPan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Boulé, N. G., Haddad, E., Kenny, G. P., Wells, G. A., & Sigal, R. J. (2001) · JAMA · doi:10.1001/jama.286.10.1218 · Cited by 1,889 · cited 2×
“(38) who conducted a meta-analysis of 14 controlled clinical trials assessing the effects of exercise on glycemic control and body mass in type 2 diabetics.”
BackgroundLindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
Borch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T., & Sekikawa, A. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.920 · Cited by 1,165
Writing committee, Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. G. M. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00835.x · Cited by 1,108 · cited 1×
“In the general population, studies have shown lifestyle modification can have beneficial effects on the diabetogenicity of an individual, especially in patients with IGT who are at high risk of developing diabetes (5, 10, 13, 16).”
BackgroundEtiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 2×
“Insulin resistance is a pathological state in which target cells fail to respond to ordinary levels of circulating insulin (35, 36).”
BackgroundPhysical Activity/Exercise and Type 2 Diabetes
Sigal, R. J., Kenny, G. P., Wasserman, D. H., & Castaneda-Sceppa, C. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2518 · Cited by 763 · cited 2×
“Suggested mechanisms include increased postreceptor insulin signaling, increased glucose transporter and messenger RNA and increased activity of glycogen synthase and hexokinase (39).”
BackgroundNEW-ONSET DIABETES AFTER TRANSPLANTATION: 2003 INTERNATIONAL CONSENSUS GUIDELINES1
Davidson, J., Wilkinson, A., Dantal, J., Dotta, F., Haller, H., Hernandez, D., Kasiske, B. L., Kiberd, B., Krentz, A., Legendre, C., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000069952.49242.3e · Cited by 676
Patient survival after renal transplantation: IV. Impact of post-transplant diabetes
Cosio, F. G., Pesavento, T. E., Kim, S., Osei, K., Henry, M., & Ferguson, R. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00582.x · Cited by 422 · cited 1×
“Cardiovascular diseases are the major cause of death in renal transplant recipients with a functioning graft, accounting for approximately 50% of all-cause mortality (1, 2).”
BackgroundCosio, F. G., Kudva, Y., van der Velde, M., Larson, T. S., Textor, S. C., Griffin, M. D., & Stegall, M. D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00349.x · Cited by 394
Effects of Exercise on Heart Rate Variability: Inferences from Meta-Analysis
SANDERCOCK, G. R. H., BROMLEY, P. D., & BRODIE, D. A. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000155388.39002.9d · Cited by 391 · cited 1×
“Resting heart rate was measured at the beginning and end of the study period as a surrogate endpoint for exercise intensity (27).”
MethodBarrett-Connor, E., & Ferrara, A. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1236 · Cited by 369
Recent Advances in Our Understanding of Insulin Action and Insulin Resistance
Le Roith, D., & Zick, Y. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.588 · Cited by 337 · cited 1×
“Insulin resistance is a pathological state in which target cells fail to respond to ordinary levels of circulating insulin (35, 36).”
BackgroundMeyer, C., Pimenta, W., Woerle, H. J., Van Haeften, T., Szoke, E., Mitrakou, A., & Gerich, J. (2006) · Diabetes Care · doi:10.2337/dc06-0438 · Cited by 308
Weyer, C., Bogardus, C., & Pratley, R. E. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2197 · Cited by 292
Risk for posttransplant diabetes mellitus with current immunosuppressive medications
Weir, M. R., & Fink, J. C. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70101-0 · Cited by 289
Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality
Shaw, J. E., Hodge, A. M., de Courten, M., Chitson, P., & Zimmet, P. Z. (1999) · Diabetologia · doi:10.1007/s001250051269 · Cited by 255
Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.
Santaguida, P. L., Balion, C. M., Hunt, D., Morrison, K. M., Gerstein, H. C., Raina, P. S., Booker, L., & Yazdi, H. (2005) · PubMed · Cited by 242
EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE AFTER RENAL TRANSPLANTATION
Kasiske, B. L. (2001) · Transplantation · doi:10.1097/00007890-200109271-00003 · Cited by 237 · cited 2×
“Cardiovascular diseases are the major cause of death in renal transplant recipients with a functioning graft, accounting for approximately 50% of all-cause mortality (1, 2).”
BackgroundIs fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies
DECODE-study group on behalf of the, T. (1999) · Diabetologia · doi:10.1007/s001250051211 · Cited by 217
Risk Factors for Development of New-Onset Diabetes Mellitus After Kidney Transplantation
Shah, T., Kasravi, A., Huang, E., Hayashi, R., Young, B., Cho, Y. W., & Bunnapradist, S. (2006) · Transplantation · doi:10.1097/01.tp.0000250756.66348.9a · Cited by 174
Postprandial glucose regulation: New data andnew implications
Leiter, L. A., Ceriello, A., Davidson, J. A., Hanefeld, M., Monnier, L., Owens, D. R., Tajima, N., & Tuomilehto, J. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.11.020 · Cited by 161 · cited 1×
“In the general population, studies have shown lifestyle modification can have beneficial effects on the diabetogenicity of an individual, especially in patients with IGT who are at high risk of developing diabetes (5, 10, 13, 16).”
BackgroundImpaired glucose tolerance and fasting hyperglycaemia have different characteristics
Davies, M. J., Raymond, N. T., Day, J., Hales, C. N., & Burden, A. C. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00246.x · Cited by 143
Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies
Eriksson, J. G., Jousilahti, P., Lindström, J., Qiao, Q., & Tuomilehto, J. O. (1999) · Cited by 130
Evaluating mechanisms of post-transplant diabetes mellitus
van Hooff, J. P. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1063 · Cited by 117
Hagen, M. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg338 · Cited by 106
Repaglinide in the Management of New-Onset Diabetes Mellitus After Renal Transplantation
Türk, T., Pietruck, F., Dolff, S., Kribben, A., Janssen, O. E., Mann, K., Philipp, T., Heemann, U., & Witzke, O. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01250.x · Cited by 98 · cited 1×
“While some of the new hypoglycemic agents have been studied in renal transplant recipients, such as repaglinide (30) and rosiglitazone (31), the older and more commonly used hypoglycemic agents have not been assessed in this particular population.”
BackgroundTHE EFFECTS OF LIPID-LOWERING AGENTS ON ACUTE RENAL ALLOGRAFT REJECTION1, 2
Kasiske, B. L., Heim-Duthoy, K. L., Singer, G. G., Watschinger, B., Germain, M. J., & Bastani, B. (2001) · Transplantation · doi:10.1097/00007890-200107270-00009 · Cited by 94
Sharif, A., Moore, R. H., & Baboolal, K. (2006) · Transplantation · doi:10.1097/01.tp.0000250924.99855.42 · Cited by 88 · cited 3×
“The methodology of the OGTT has been previously described (25).”
BackgroundMethodSelf-citationTransplant-Associated Hyperglycemia: A New Look at an Old Problem
Crutchlow, M. F., & Bloom, R. D. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03671106 · Cited by 88
Voytovich, M. H., Simonsen, C., Jenssen, T., Hjelmesaeth, J., Asberg, A., & Hartmann, A. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh641 · Cited by 60 · cited 1×
“While some of the new hypoglycemic agents have been studied in renal transplant recipients, such as repaglinide (30) and rosiglitazone (31), the older and more commonly used hypoglycemic agents have not been assessed in this particular population.”
BackgroundDeterminants of Insulin Resistance in Renal Transplant Recipients
Oterdoom, L. H., de Vries, A. P. J., Gansevoort, R. T., van Son, W. J., van der Heide, J. J. H., Ploeg, R. J., de Jong, P. E., Gans, R. O. B., & Bakker, S. J. L. (2007) · Transplantation · doi:10.1097/01.tp.0000245844.27683.48 · Cited by 50 · cited 1×
“Obesity, inadequate diet, and physical inactivity all contribute to decreasing insulin sensitivity (35, 37).”
BackgroundHeldgaard, P. E., Olivarius, N. D. F., Hindsberger, C., & Henriksen, J. E. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01231.x · Cited by 37
Meisinger, C., Wölke, G., Brasche, S., Strube, G., & Heinrich, J. (2006) · Annals of Epidemiology · doi:10.1016/j.annepidem.2005.10.008 · Cited by 32
The burden of new‐onset diabetes mellitus after transplantation
Moore, R. H., Ravindran, V. K., & Baboolal, K. (2006) · Clinical Transplantation · doi:10.1111/j.1399-0012.2006.00565.x · Cited by 21 · cited 1×
“NODAT is becoming a major clinical burden after transplantation (29).”
BackgroundSelf-citationNew‐onset diabetes after kidney transplantation
GIANNARELLI, R., Coppelli, A., Boggi, U., Rizzo, G. E., Barsotti, M., Palaeologo, G., Tregnaghi, C., Mosca, F., Prato, S. D., & Marchetti, P. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01621.x · Cited by 6 · cited 1×
“New-onset diabetes after transplantation (NODAT) is a major contributor to the burden of cardiovascular disease (1, 3).”
Background
Research works printed but not linked: 1
- 2006, Standards of medical care in diabetes—2006., Diabetes Care, 29, S4
Cited by
Sharif, A., Hecking, M., de Vries, A. P. J., Porrini, E., Hornum, M., Rasoul-Rockenschaub, S., Berlakovich, G., Krebs, M., Kautzky-Willer, A., Schernthaner, G., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12850 · Cited by 532
“Sharif et al (46) demonstrated the potential for benefit from lifestyle modification in kidney allograft recipients with impaired glucose tolerance (13/25 patients reverted to normal glucose tolerance after median of 9 months, with only 1 progressing to PTDM).”
BackgroundSelf-citationExercise training for adults with chronic kidney disease
Heiwe, S., & Jacobson, S. H. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003236.pub2 · Cited by 481
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Shivaswamy, V., Boerner, B., & Larsen, J. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1084 · Cited by 328
Physical inactivity: a risk factor and target for intervention in renal care
Zelle, D. M., Klaassen, G., van Adrichem, E., Bakker, S. J. L., Corpeleijn, E., & Navis, G. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.187 · Cited by 282
Metadata
- Authors
- Sharif, A., Moore, R., & Baboolal, K.
- Affiliations
- University Hospital of Wales (GB)
- Corresponding author
- Sharif, Adnan
- Venue
- Transplantation
- Published
- 2008-02-15
- Volume
- 85
- Issue
- 3
- Pages
- 353-358
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1968567860
- Cited by
- 144
- References
- 39
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 7 · 2023: 5 · 2022: 7 · 2021: 13 · 2020: 14 · 2019: 5 · 2018: 14 · 2017: 5 · 2016: 7 · 2015: 14 · 2014: 13 · 2013: 8 · 2012: 7
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- lifestyle modification, kidney transplant recipients, postprandial hyperglycemia, post-transplant diabetes mellitus, impaired glucose tolerance, oral glucose tolerance test, exercise program, dietician referral, weight loss advice
- MeSH terms
- Female, Humans, Hyperglycemia, Life Style, Male, Middle Aged, Kidney Transplantation, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.